107 related articles for article (PubMed ID: 36750540)
41. [Detection of HPV16 E6 gene in cervical tissues by quantitative polymerase chain reaction].
Ma CL; Li YJ; Zhang FC; Wang GQ; Zheng YJ; Kai LM; Re XD; Han Y; Patiguli
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):469-73. PubMed ID: 15061964
[TBL] [Abstract][Full Text] [Related]
42. A novel multiplex real-time PCR assay for the detection and quantification of HPV16/18 and HSV1/2 in cervical cancer screening.
Zhao Y; Cao X; Tang J; Zhou L; Gao Y; Wang J; Zheng Y; Yin S; Wang Y
Mol Cell Probes; 2012 Apr; 26(2):66-72. PubMed ID: 22293505
[TBL] [Abstract][Full Text] [Related]
43. Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer.
Castle PE; Schiffman M; Scott DR; Sherman ME; Glass AG; Rush BB; Schussler JE; Wacholder S; Lorincz AT
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1311-4. PubMed ID: 15894692
[TBL] [Abstract][Full Text] [Related]
44. Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trials.
Zhang Y; Du H; Xiao A; Zhang W; Wang C; Huang X; Qu X; Wang J; Wu R
Infect Agent Cancer; 2022 Jun; 17(1):27. PubMed ID: 35690793
[TBL] [Abstract][Full Text] [Related]
45. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X
J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of type-specific HPV persistence and high-risk HPV viral load quantitation in HPV positive women under 30 with normal cervical cytology.
Carcopino X; Bolger N; Henry M; Mancini J; Boubli L; Olive D; Cleary S; Prendiville W; Tamalet C
J Med Virol; 2011 Apr; 83(4):637-43. PubMed ID: 21328378
[TBL] [Abstract][Full Text] [Related]
47. Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins.
Di Bonito P; Grasso F; Mochi S; Accardi L; Donà MG; Branca M; Costa S; Mariani L; Agarossi A; Ciotti M; Syrjänen K; Giorgi C
Infect Agent Cancer; 2006 Nov; 1():6. PubMed ID: 17150135
[TBL] [Abstract][Full Text] [Related]
48. Methylation of CpG 5962 in L1 of the human papillomavirus 16 genome as a potential predictive marker for viral persistence: A prospective large cohort study using cervical swab samples.
Fertey J; Hagmann J; Ruscheweyh HJ; Munk C; Kjaer S; Huson D; Haedicke-Jarboui J; Stubenrauch F; Iftner T
Cancer Med; 2020 Feb; 9(3):1058-1068. PubMed ID: 31856411
[TBL] [Abstract][Full Text] [Related]
49. Some novel insights on HPV16 related cervical cancer pathogenesis based on analyses of LCR methylation, viral load, E7 and E2/E4 expressions.
Das Ghosh D; Bhattacharjee B; Sen S; Premi L; Mukhopadhyay I; Chowdhury RR; Roy S; Sengupta S
PLoS One; 2012; 7(9):e44678. PubMed ID: 22970286
[TBL] [Abstract][Full Text] [Related]
50. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia.
Xi LF; Koutsky LA; Galloway DA; Kuypers J; Hughes JP; Wheeler CM; Holmes KK; Kiviat NB
J Natl Cancer Inst; 1997 Jun; 89(11):796-802. PubMed ID: 9182978
[TBL] [Abstract][Full Text] [Related]
51. Integrative and episomal forms of genotype 16 of human papillomavirus in patients with cervical intraepithelial neoplasia and cervical cancer.
Ibragimova MK; Tsyganov MM; Karabut IV; Churuksaeva ON; Shpileva ON; Bychkov VA; Kolomiets LA; Litviakov NV
Vopr Virusol; 2016 Dec; 61(6):270-274. PubMed ID: 36494986
[TBL] [Abstract][Full Text] [Related]
52. HPV16 E6 polymorphism and physical state of viral genome in relation to the risk of cervical cancer in women from the south of Poland.
Szostek S; Zawilinska B; Klimek M; Kosz-Vnenchak M
Acta Biochim Pol; 2017; 64(1):143-149. PubMed ID: 27801430
[TBL] [Abstract][Full Text] [Related]
53. Correlation between viral load, multiplicity of infection, and persistence of HPV16 and HPV18 infection in a Dutch cohort of young women.
van der Weele P; van Logchem E; Wolffs P; van den Broek I; Feltkamp M; de Melker H; Meijer CJ; Boot H; King AJ
J Clin Virol; 2016 Oct; 83():6-11. PubMed ID: 27522635
[TBL] [Abstract][Full Text] [Related]
54. Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies.
Wang JW; Jagu S; Wu WH; Viscidi RP; Macgregor-Das A; Fogel JM; Kwak K; Daayana S; Kitchener H; Stern PL; Gravitt PE; Trimble CL; Roden RB
Clin Vaccine Immunol; 2015 Jul; 22(7):806-16. PubMed ID: 25972404
[TBL] [Abstract][Full Text] [Related]
55. Human papillomavirus load and genotype analysis improves the prediction of invasive cervical cancer.
Hortlund M; van Mol T; Van de Pol F; Bogers J; Dillner J
Int J Cancer; 2021 Aug; 149(3):684-691. PubMed ID: 33586149
[TBL] [Abstract][Full Text] [Related]
56. Clinical Performance of APTIMA Human Papillomavirus (HPV) 16 18/45 mRNA Genotyping Testing for the Detection of Cervical Intraepithelial Neoplasia 3 (CIN3) or Cancer in a Select Group of Chinese Women.
Guo YL; You K; Geng L; Qiao J
Pathol Oncol Res; 2016 Jul; 22(3):549-54. PubMed ID: 26710763
[TBL] [Abstract][Full Text] [Related]
57. Development and interlaboratory agreement of real-time PCR for HPV16 quantification in liquid-based cervical samples.
Guenat D; Dalstein V; Mauny F; Saunier M; Briolat J; Clavel C; Riethmuller D; Mougin C; Prétet JL
Papillomavirus Res; 2018 Dec; 6():27-32. PubMed ID: 30343011
[TBL] [Abstract][Full Text] [Related]
58. [Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer].
Wang JT; Ding L; Gao ES; Cheng YY
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):968-71. PubMed ID: 18399141
[TBL] [Abstract][Full Text] [Related]
59. Is human papillomavirus viral load a clinically useful predictive marker? A longitudinal study.
Constandinou-Williams C; Collins SI; Roberts S; Young LS; Woodman CB; Murray PG
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):832-7. PubMed ID: 20200441
[TBL] [Abstract][Full Text] [Related]
60. Triage options to manage high-risk human papillomavirus-positive women: A population-based cross-sectional study from rural China.
Rezhake R; Chen F; Hu SY; Zhao XL; Zhang X; Cao J; Qiao YL; Zhao FH; Arbyn M
Int J Cancer; 2020 Oct; 147(8):2053-2064. PubMed ID: 32249409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
